Trifecta Medical Group Clarifies No Relationship With Eli Lilly or LillyDirect Platform

Trifecta Med Spa, Trifecta Health, and Edward Fruitman, M.D. have issued a formal correction addressing recent online statements about their business relationships. The medical group clarified that it does not maintain any contractual relationship, partnership, agreement, affiliation, or cooperation arrangement with Eli Lilly, LillyDirect®, or any Eli Lilly subsidiary. This clarification comes amid circulating information that suggested potential connections between the medical practices and the pharmaceutical giant.

The correction specifically addresses concerns about product preferences and exclusive arrangements. Trifecta stated it does not endorse, promote, or show preference for any Eli Lilly products, including Zepbound®, in the course of its medical or weight-loss services. This distinction is significant for patients seeking unbiased medical advice and treatment options in the competitive weight management sector where pharmaceutical partnerships can influence prescribing patterns.

Trifecta emphasized its commitment to working with multiple pharmacy providers, stating it will continue to cooperate with any licensed pharmacy or pharmacy service provider that can offer the best quality of care, value, and pricing for its patients. The medical group explicitly stated it has not entered—nor does it plan to enter—into any exclusive pharmacy arrangement, product preference policy, or partnership with Eli Lilly or LillyDirect®.

This clarification matters because it addresses growing concerns about transparency in healthcare relationships between medical providers and pharmaceutical companies. As weight-loss medications become increasingly popular and competitive, patients need assurance that their healthcare providers are making treatment decisions based on medical evidence rather than corporate partnerships. The statement reinforces Trifecta's position as an independent provider free from manufacturer influence.

The impact extends beyond individual patient care to the broader healthcare industry, where exclusive arrangements between medical practices and pharmaceutical companies can limit treatment options and potentially increase costs. By maintaining independence from specific manufacturers, Trifecta positions itself to offer patients a wider range of treatment options based on individual needs rather than corporate agreements.

Trifecta Health and Trifecta Med Spa reiterated their commitment to providing evidence-based, patient-centered weight-loss and wellness services. The organization maintains that its medical decisions are driven by patient needs and clinical evidence rather than external commercial influences. For additional information about their services, visit https://trifectamedspanyc.com/weight-management-program.